Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| May 29, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +631 | $8.91 | $5,622 |
| May 18, 2026 | BioCryst Pharmaceuticals Inc. | Open-market sale | −11,180 | $8.97 | $100,285 |
| Feb 27, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +642 | $8.75 | $5,618 |
| Nov 28, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +783 | $7.18 | $5,622 |
| Aug 29, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +676 | $8.31 | $5,618 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Jun 24, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −8,600 | $6.32 | $54,352 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.